CAROCCI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 6.489
EU - Europa 1.537
AS - Asia 873
SA - Sud America 11
OC - Oceania 5
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.919
Nazione #
US - Stati Uniti d'America 6.482
CN - Cina 601
SE - Svezia 437
IT - Italia 309
UA - Ucraina 198
DE - Germania 195
FI - Finlandia 122
VN - Vietnam 114
GB - Regno Unito 104
SG - Singapore 100
FR - Francia 85
IN - India 23
IE - Irlanda 22
BE - Belgio 15
NL - Olanda 14
IR - Iran 11
CH - Svizzera 9
CA - Canada 6
LV - Lettonia 6
RU - Federazione Russa 6
BR - Brasile 4
HK - Hong Kong 4
KR - Corea 4
AU - Australia 3
CL - Cile 3
CZ - Repubblica Ceca 3
ID - Indonesia 3
JP - Giappone 3
PL - Polonia 3
ES - Italia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RO - Romania 2
TR - Turchia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AT - Austria 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 8.919
Città #
Fairfield 911
Chandler 617
Woodbridge 537
Houston 472
Ashburn 468
Jacksonville 455
Seattle 377
Nyköping 348
Cambridge 331
Wilmington 327
Ann Arbor 236
Lawrence 148
Roxbury 146
Bari 137
Nanjing 128
New York 125
Dong Ket 111
Beijing 104
Des Moines 84
Princeton 83
Singapore 82
Boardman 68
Brooklyn 45
San Diego 45
Los Angeles 42
Inglewood 41
Shenyang 33
Jiaxing 29
Redwood City 29
Santa Clara 29
Hebei 27
Nanchang 27
Guangzhou 21
Munich 21
Tianjin 21
Dublin 20
Marseille 19
Changsha 17
Dearborn 17
London 17
Shanghai 17
Brussels 14
Paris 13
Falls Church 12
Norwalk 12
Pune 12
San Mateo 12
Jinan 10
Ardabil 9
Hefei 9
Leawood 9
Augusta 8
West Jordan 8
Wuhan 8
Amsterdam 7
Milan 7
Bitonto 6
Grafing 6
Grumo Appula 6
Kansas City 6
Toronto 6
Washington 6
Rome 5
San Francisco 5
Zhengzhou 5
Helsinki 4
Indiana 4
Kilburn 4
Kunming 4
Mumbai 4
Ningbo 4
Nuremberg 4
Riga 4
Sannicandro di Bari 4
Shenzhen 4
St Albans 4
Taizhou 4
Triggiano 4
Wuxi 4
Auburn Hills 3
Belém 3
Boydton 3
Brno 3
Cedar Knolls 3
Chicago 3
Chongqing 3
Florence 3
Hanoi 3
Islington 3
Lentini 3
Monmouth Junction 3
Zhenjiang 3
Acton 2
Andover 2
Auckland 2
Bologna 2
Brescia 2
Dongguan 2
Dundaga 2
Düsseldorf 2
Totale 7.124
Nome #
1, 3‐Benzothiazoles as Antimicrobial Agents 240
1,3-Benzothiazoles as Antimicrobial Agents 229
Acidi carbossilici derivati dell'antracene e suoi isosteri: effetti sulla conduttanza al cloro 134
1-Pentanoyl-N-{[2’-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-pyrrolidine-2-carboxamide: Investigation of Structural Variations 130
Antiarrhythmic mexiletine: A review on synthetic routes to racemic and homochiral mexiletine and its enantioseparation 125
2-Aminobenzothiazole derivatives: Search for new antifungal agents 122
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity 120
A convenient synthesis of lubeluzole and its enantiomer: Evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells 117
Synthesis and evaluation of berberine derivatives and analogs as potential antiacetylcholinesterase and antioxidant agents 110
A Mini-Review on Thalidomide: Chemistry, Mechanisms of Action, Therapeutic Potential and Anti-Angiogenic Properties in Multiple Myeloma 110
Searching for new antiarrhythmic agents: evaluation of meta-hydroxymexiletine enantiomers 103
null 103
Mercury exposure and heart diseases 102
Facile entry to (-)-R- and (+)-(S)-mexiletine 101
N-(Phenoxyalkyl)amides as MT1 and MT2 ligands: Antioxidant properties and inhibition of Ca2+/CaM-dependent kinase II 101
Constrained analogues of tocainide as potent skeletal muscle sodium channel blockers towards the development of antimyotonic agents 101
Lead toxicity, antioxidant defense and environment 99
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp 99
Organofluorinecontaining anti-infective agents 97
Capillary zone electrophoresis for separation and quantitative determination of mexiletine and its main phase i metabolites 96
,3-Benzothiazoles as Antimicrobial Agents 95
Inhibition of voltage-gated sodium channels by sumatriptan bioisosteres 95
Hydroxylated analogs of mexiletine as tools for structural-requirements investigation of the sodium channel blocking activity 93
Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos 93
Microwave-assisted synthesis of KN-93, a potent and selective inhibitor of Ca2+/calmoduline-dependent protein kinase II 92
Old drug scaffold, new activity: Thalidomide-correlated compounds exert different effects on breast cancer cell growth and progression 91
null 90
Acetyl-L-Carnitine in Parkinson’s Disease 89
Searching for novel anti-myotonic agents: Pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide 89
null 89
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 88
Oxidative stress and neurodegeneration: the involvement of iron 88
A Review on Mercury Toxicity in Food 88
Facile routes for the preparation of 3,4-disubstituted 1,3-oxazolidines and 1,2,5-trisubstituted imidazolidin-4-ones 87
Stereoselective Modulation of P-Glycoprotein by Chiral Small Molecules 86
Antiproliferative activity evaluation of a series of N-1,3-benzothiazol-2-ylbenzamides as novel apoptosis inducers 86
A Focus on the Synthesis and Pharmacokinetics of Tocainide and its Analogues 86
Chiral aryloxyalkylamines: selective 5-HT1B/1D activation and analgesic activity 84
AT1 receptor ligands: virtual screening based design with TOPP descriptors, synthesis and biological evaluation of pyrrolidine derivatives 83
Microwave assisted synthesis of (±)-mandelic acid-d5, optical resolution, and absolute configuration determination 81
Facile, alternative route to Lubeluzole, its enantiomer, and the racemate 80
Optically active mexiletine analogues as stereoselective blockers of voltage-gated Na+ channels 79
Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues 79
Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors 78
Mexiletine metabolites: A review 78
Effect of Methyl -β- Cyclodextrin on the antimicrobial activity of a new series of poorly water-soluble benzothiazoles 78
Melatonergic drugs in development 76
One-step synthesis of homochiral O-aryl and O-heteroaryl mandelic acids and their use as efficient 1H NMR chiral solvating agents 76
Arilossialchilammine come ligandi per i recettori 5-HT1B/1D: Bioisosteria, chiralità e selettività 75
Stereospecific Synthesis of ‘‘para-Hydroxymexiletine’’ and Sodium Channel Blocking Activity Evaluation 75
Stereospecific synthesis of mexiletine and related compounds: Mitsunobu versus Williamson reaction 72
Optically active Mexiletine analogues as stereoselective blockers of voltage-gated Na+ channels 71
Melatonin in Parkinson’s Disease 69
2-(9-Antryl)alcanoic acids as chloride channel modulators 69
null 69
null 68
Dual action of mexiletine and its pyrroline derivatives as skeletal muscle sodium channel blockers and anti-oxidant compounds: Toward novel therapeutic potential 68
Anti-biofilm inhibitory synergistic effects of combinations of essential oils and antibiotics 68
Molecular insights into the local anesthetic receptor within voltage-gated sodium channels using hydroxylated analogs of mexiletine 67
Facile Entry to Ethyl Tetrahydro-1H-pyrrolizin-7a(5H)-ylacetate: a Versatile Pharmaceutical Intermediate 66
alpha-Glucosidase inhibitors: SAR studies on N-(aryloxyalkyl)phthalimides and their isosters 66
Synthesis and in vitro sodium channel blocking activity evaluation of novel homochiral mexiletine analogs 65
Synthesis and antimicrobial evaluation of a new series of N-1,3-benzothiazol-2-ylbenzamides 65
null 65
An improved synthesis of m-hydroxymexiletine, a potent mexiletine metabolite 64
Synthesis of (R)-, (S)-, and (RS)-hydroxymethylmexiletine one of the major metabolites of mexiletine 63
Mercury toxicity and neurodegenerative effects 63
Newly synthesized mexiletine and tocainide analogues are potent use-dependent blockers of skeletal muscle sodium channels: potential implication for antimyotonic activity 61
Alpha-glucosidase inhibitors: SAR studies on N-(aryloxyalkyl)phthalimides and their isosters 60
Analoghi chirali della mexiletina: blocco stereoselettivo dei canali per gli ioni sodio e ipotesi sull’interazione recettoriale 59
Chiral mexiletine analogues as skeletal muscle voltage-gated sodium channel blocking agents 59
Finding solutions for agricultural wastes: Antioxidant and antitumor properties of pomegranate Akko peel extracts and β-glucan recovery† 59
New N-(phenoxydecyl)phthalimide derivatives displaying potent inhibition activity towards alpha-glucosidase 58
a-Glucosidase inhibitors: SAR studies on N-(aryloxyalkyl)phthalimides and their isosters 57
Stereospecific Synthesis of p-Hydroxymexiletine and Hydroxymethylmexiletine: the two Main Metabolites of Mexiletine 57
Derivati idrossilati della mexiletina come tools farmacologici nello studio dell'attività di blocco dei canali sodici 57
Synthesis and Evaluation of Voltage-Gated Sodium Channel Blocking Pyrroline Derivatives Endowed with Both Antiarrhythmic and Antioxidant Activities 56
ANTIARRHYTHMIC AGENTS ENDOWED WITH ANTIOXIDANT PROPERTIES 54
Structure-activity relationships in the sodium channel blocking activity of mexiletine analogues 54
Large screening of newly synthesized Mexiletine and Tocanide analogs as potent use-dependent blockers of skeletal muscle sodium channels: identification of the structural requirements for improving antimyotonic activity 53
Novel insights in health-promoting properties of sweet cherries 52
Mexiletine analogues as potent skeletal muscle sodium channel blockers: hypotheses on the interactions at the main binding sites 51
Pilsicainide and its oxymethylene analog: Facile alternative synthesis and in vitro testing on human skeletal muscle sodium channels 51
Separation and quantitative determination of mexiletine and its metabolites by capillary zone electrophoresis 48
Synthesis of 7a-[2(2,6-dimethylphenoxy)ethyl]hexahydro-1H-pyrrolizine, bioisostere of pilsicainide 48
null 48
Metabolic derivatives of antiarrhythmic drugs: stereospecific synthesis of N-hydroxymexiletine and meta-hydroxymexiletine 47
Arilossialchilammine come ligandi per i recettori 5-HT1B/1D: Bioisosteria, chiralità e selettività 45
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 45
Metabolic derivatives of antiarrhythmic drugs: stereospecific synthesis of N-hydroxymexiletine and meta-hydroxymexiletine 44
Antagonisti non peptidici del recettore dell’angiotensina II: analisi PLS, disegno razionale e sintesi di nuovi derivati 44
Sintesi alternativa del lubeluzolo e del suo enantiomero e valutazione come agenti in grado di potenziare l'effetto di farmaci antitumorali. 44
Pomegranate: Nutraceutical with promising benefits on human health 44
null 44
Separazione e determinazione quantitativa dei principali prodotti di degradazione metabolica e chimica della mexiletina mediante elettroforesi capillare zonale 43
Synthesis, anticancer and antioxidant properties of new indole and pyranoindole derivatives 43
Derivati 1-acilpirrolidin-2-carbossammidici: sintesi e valutazione dell’attività sui recettori AT1 42
Evaluation of the dual action of new derivatives of mexiletine as usedependent sodium channel blockers and antioxidant: potential therapeutic application in neuromuscular disorders 42
Partial kinetic resolution of rac-2-phenylbutyric acid with omochiral 2-phenylethylamines and 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline 41
Practical and efficient synthesis of beta-proline derivatives as sodium channel blockers 41
Totale 7.775
Categoria #
all - tutte 40.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.648 0 0 81 190 214 135 211 165 248 119 232 53
2020/20211.776 287 62 129 87 158 132 125 93 163 208 144 188
2021/20221.110 59 192 15 33 20 69 86 43 65 69 164 295
2022/20231.712 284 170 102 147 193 242 11 191 259 19 40 54
2023/2024708 45 94 24 60 39 170 18 35 15 33 80 95
2024/2025331 88 66 177 0 0 0 0 0 0 0 0 0
Totale 9.362